Kristopher W. Krausz

18.5k citations

201 papers · 13.6k indexed · 5 hit papers · h-index 64

Pharmacology top 0.02%
- Pharmacogenetics and Drug Metabolism 63
- Drug-Induced Hepatotoxicity and Protection 20
Oncology top 0.5%
- Drug Transport and Resistance Mechanisms 57
Biological Psychiatry top 1%
Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology 13
Molecular Biology top 0.5%
- Metabolomics and Mass Spectrometry Studies 39
- Peroxisome Proliferator-Activated Receptors 21
Epidemiology
- Liver Disease Diagnosis and Treatment 30
Cancer Research
- Cancer, Hypoxia, and Metabolism 14

Co-authors: Frank J. Gonzalez Jeffrey R. Idle Andrew D. Patterson Cen Xie Changtao Jiang Xiaochao Ma Fei Li Harry V. Gelboin
Cited by: Pharmacology Oncology Biological Psychiatry
Partner nations: United States China Switzerland

In The Last Decade

Kristopher W. Krausz

200 papers receiving 13.4k citations

Hit Papers

5 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2018 Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolism
2017 Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota
2015 Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
2014 Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
2013 Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

Peers

Countries citing papers authored by Kristopher W. Krausz

Since Specialization

Citations

This map shows the geographic impact of Kristopher W. Krausz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristopher W. Krausz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristopher W. Krausz more than expected).

Fields of papers citing papers by Kristopher W. Krausz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristopher W. Krausz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristopher W. Krausz. The network helps show where Kristopher W. Krausz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kristopher W. Krausz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kristopher W. Krausz Line = papers co-authored together Kristopher W. Krausz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Intestinal stearoyl-coenzyme A desaturase-inhibition improves obesity-associated metabolic disorders Yangliu Xia,Yang Zhang,Zhipeng Zhang,Nana Yan,Vorthon Sawaswong,Lulu Sun,Wei Guo,Ping Wang,Kristopher W. Krausz,Oksana Gavrilova,James M. Ntambi,Haiping Hao,Tingting Yan,Frank J. Gonzalez	2024	4
2	Urinary Metabolite Diagnostic and Prognostic Liquid Biopsy Biomarkers of Lung Cancer in Nonsmokers and Tobacco Smokers Bhavik Dalal,Takeshi Tada,Daxesh P. Patel,Sharon R. Pine,Mohammed Khan,Takahiro Oike,Yasuyuki Kanke,Amelia L. Parker,Majda Haznadar,Leila Toulabi,Kristopher W. Krausz,Ana I. Robles,Elise D. Bowman,Frank J. Gonzalez,Curtis C. Harris	2024	1
3	Activation of Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) in Keratinocytes by Endogenous Fatty Acids Bokai Zhu,Xiaoyang Zhu,Michael G. Borland,Douglas Ralph,Christopher Chiaro,Kristopher W. Krausz,James M. Ntambi,Adam B. Glick,Andrew D. Patterson,Gary H. Perdew,Frank J. Gonzalez,Jeffrey M. Peters	2024	1
4	Creatine riboside is a cancer cell–derived metabolite associated with arginine auxotrophy Amelia L. Parker,Leila Toulabi,Takahiro Oike,Yasuyuki Kanke,Daxeshkumar Patel,Takeshi Tada,Sheryse Taylor,Jessica A. Beck,Elise D. Bowman,Michelle L. Reyzer,Donna Butcher,Skyler A. Kuhn,Gary T. Pauly,Kristopher W. Krausz,Frank J. Gonzalez,S. Perwez Hussain,Stefan Ambs,Bríd M. Ryan,Xin Wei Wang,Curtis C. Harris	2022	5
5	Mutant Idh2 Cooperates with a NUP98-HOXD13 Fusion to Induce Early Immature Thymocyte Precursor ALL Liat Goldberg,Vijay Negi,Yang Jo Chung,Masahiro Onozawa,Yuelin J. Zhu,Robert L. Walker,Rachel Pierce,Daxesh P. Patel,Kristopher W. Krausz,Frank J. Gonzalez,Margaret A. Goodell,Blanca Rodríguez,Paul S. Meltzer,Peter D. Aplan	2021	8
6	Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma Majda Haznadar,Christopher M. Diehl,Amelia L. Parker,Kristopher W. Krausz,Elise D. Bowman,Siritida Rabibhadana,Marshonna Forgues,Vajarabhongsa Bhudhisawasdi,Frank J. Gonzalez,Chulabhorn Mahidol,Anuradha Budhu,Xin Wei Wang,Mathuros Ruchirawat,Curtis C. Harris	2019	15
7	Inverse association of vitamin D₃ levels with lung cancer mediated by genetic variation Majda Haznadar,Kristopher W. Krausz,Ezra Margono,Christopher M. Diehl,Elise D. Bowman,Soumen Manna,Ana I. Robles,Bríd M. Ryan,Frank J. Gonzalez,Curtis C. Harris	2018	14
8	Metabolic Profiling of the Novel Hypoxia-Inducible Factor 2α Inhibitor PT2385 In Vivo and In Vitro Cen Xie,Xiaoxia Gao,Dongxue Sun,You-Bo Zhang,Kristopher W. Krausz,Xuemei Qin,Frank J. Gonzalez	2018	24
9	Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms Dhaval Patel,Matthew D. Thompson,Soumen Manna,Kristopher W. Krausz,Lisa Zhang,Naris Nilubol,Frank J. Gonzalez,Electron Kebebew	2017	17
10	Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides Zifei Qin,Shishi Li,Zhihong Yao,Xiaodan Hong,Baojian Wu,Kristopher W. Krausz,Frank J. Gonzalez,Hao Gao,Xin‐Sheng Yao	2017	16
11	Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis Cen Xie,Tomoki Yagai,Yuhong Luo,Xianyi Liang,Tao Chen,Qiong Wang,Dongxue Sun,Jie Zhao,Sadeesh K. Ramakrishnan,Lulu Sun,Chunmei Jiang,Xiang Xue,Yuan Tian,Kristopher W. Krausz,Andrew D. Patterson,Yatrik M. Shah,Yue Wu,Changtao Jiang,Frank J. Gonzalez	2017	128
12	Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study Majda Haznadar,Qiuyin Cai,Kristopher W. Krausz,Elise D. Bowman,Ezra Margono,Rintaro Noro,Matthew D. Thompson,Ewy A. Mathé,Heather M. Munro,Mark Steinwandel,Frank J. Gonzalez,William J. Blot,Curtis C. Harris	2016	45
13	Mass Spectrometry–Based Metabolomics Identifies Longitudinal Urinary Metabolite Profiles Predictive of Radiation-Induced Cancer John A. Cook,Gadisetti V.R. Chandramouli,Miriam R. Anver,Anastasia L. Sowers,Angela Thetford,Kristopher W. Krausz,Frank J. Gonzalez,James B. Mitchell,Andrew D. Patterson	2016	13
14	St. John's Wort Attenuates Colorectal Carcinogenesis in Mice through Suppression of Inflammatory Signaling Soumen K. Manna,Srujana Golla,Jaya Prakash Golla,Naoki Tanaka,Yan Cai,Shogo Takahashi,Kristopher W. Krausz,Tsutomu Matsubara,Ilia Korboukh,Frank J. Gonzalez	2015	10
15	Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet Naoki Tanaka,Shogo Takahashi,Yuan Zhang,Kristopher W. Krausz,Philip B. Smith,Andrew D. Patterson,Frank J. Gonzalez	2015	100
16	Noninvasive Urinary Metabolomic Profiling Identifies Diagnostic and Prognostic Markers in Lung Cancer Ewy A. Mathé,Andrew D. Patterson,Majda Haznadar,Soumen Manna,Kristopher W. Krausz,Elise D. Bowman,Peter G. Shields,Jeffrey R. Idle,Philip B. Smith,Katsuhiro Anami,Dickran Kazandjian,Emmanuel Hatzakis,Frank J. Gonzalez,Curtis C. Harris	2014	142
17	Novel metabolites and roles for α-tocopherol in humans and mice discovered by mass spectrometry–based metabolomics Caroline H. Johnson,Ondřej Slanař,Kristopher W. Krausz,Dong Wook Kang,Andrew D. Patterson,Jung Hwan Kim,Hans Luecke,Frank J. Gonzalez,Jeffrey R. Idle	2012	44
18	Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Plasma Metabolomics and Lipid Profiling Andrew D. Patterson,Olivier Maurhofer,Diren Beyoğlu,Christian Lanz,Kristopher W. Krausz,Thomas Pabst,Frank J. Gonzalez,Jean‐François Dufour,Jeffrey R. Idle	2011	224
19	A Metabolomic Perspective of Melatonin Metabolism in the Mouse Xiaochao Ma,Chi Chen,Kristopher W. Krausz,Jeffrey R. Idle,Frank J. Gonzalez	2008	48
20	Potential Role for Human Cytochrome P450 3A4 in Estradiol Homeostasis Ai‐Ming Yu,Katsumi Fukamachi,Kristopher W. Krausz,Connie Cheung,Frank J. Gonzalez	2005	65

About Kristopher W. Krausz

Kristopher W. Krausz is a scholar working on Pharmacology, Biochemistry and Oncology, having authored 201 papers that have together received 13.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (63 papers), Drug Transport and Resistance Mechanisms (57 papers), Metabolomics and Mass Spectrometry Studies (39 papers), Liver Disease Diagnosis and Treatment (30 papers), Peroxisome Proliferator-Activated Receptors (21 papers), Drug-Induced Hepatotoxicity and Protection (20 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Eicosanoids and Hypertension Pharmacology (13 papers). The work is most often cited by research in Pharmacology (3.4k citations), Oncology (3.3k citations) and Biological Psychiatry (292 citations). Kristopher W. Krausz has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Frank J. Gonzalez, Jeffrey R. Idle, Andrew D. Patterson, Cen Xie, Changtao Jiang, Xiaochao Ma, Fei Li, Harry V. Gelboin, Naoki Tanaka and Magang Shou.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact